Natera(NTRA.US)

Event Tracking

Jan6

Natera to Present New Data from the ALTAIR Clinical Trial at the 2026 ASCO GI

00:25

Jan5

Natera Launches Extended 21-gene Fetal Focus Non-invasive Prenatal Test

12:01

Jan3

Zacks Raises Natera Rating, Several Companies Increase Target Price

11:02

Dec28

Vontobel Holding Ltd. Increased Holdings in Natera, Inc. by 192.5% in Third Quarter

13:20

Dec27

SWS Partners Increases Stake in Natera

11:50

Dec23

Natera Inc. Director Jonathan Sheena Reports Disposition of Common Stock

01:05

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 592.18 M, Net Income -87.54 M, EPS -0.6381

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 546.6 M, Net Income -100.94 M, EPS -0.74

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 501.83 M, Net Income -66.94 M, EPS -0.4967

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change